PubMed

Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors.

Rönnblom LE, Alm GV, Oberg KE.

Ann Intern Med. 1991 Aug 1;115(3):178-83.PMID: 2058872 [PubMed - indexed for MEDLINE]Related articles

Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity.

Oberg K, Alm G, Magnusson A, Lundqvist G, Theodorsson E, Wide L, Wilander E.

J Natl Cancer Inst. 1989 Apr 5;81(7):531-5.PMID: 2466128 [PubMed - indexed for MEDLINE]Related articles

Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment.

Rönnblom LE, Alm GV, Oberg K.

Acta Oncol. 1991;30(4):537-40.PMID: 1854511 [PubMed - indexed for MEDLINE]Related articles

Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.

Chung YH, Shong YK.

Am J Gastroenterol. 1993 Feb;88(2):244-7.PMID: 8424429 [PubMed - indexed for MEDLINE]Related articles

Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.

Floreani A, Chiaramonte M, Greggio NA, Fabris P, De Lazzari F, Naccarato R, Betterle C.

Ital J Gastroenterol Hepatol. 1998 Feb;30(1):71-6.PMID: 9615270 [PubMed - indexed for MEDLINE]Related articles

Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.

Oberg K, Norheim I, Lind E, Alm G, Lundqvist G, Wide L, Jonsdottir B, Magnusson A, Wilander E.

Cancer Treat Rep. 1986 Nov;70(11):1297-304.PMID: 2429764 [PubMed - indexed for MEDLINE]Related articles

Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.

Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G.

J Clin Endocrinol Metab. 2001 May;86(5):1925-9.PMID: 11344186 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.

Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N.

Am J Gastroenterol. 1994 Mar;89(3):399-403.PMID: 8122653 [PubMed - indexed for MEDLINE]Related articles

A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.

Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.

Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.PMID: 9164512 [PubMed - indexed for MEDLINE]Related articles

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.

Marazuela M, García-Buey L, González-Fernández B, García-Monzón C, Arranz A, Borque MJ, Moreno-Otero R.

Clin Endocrinol (Oxf). 1996 Jun;44(6):635-42.PMID: 8759175 [PubMed - indexed for MEDLINE]Related articles

Autoantibodies during alpha-interferon therapy for chronic hepatitis B.

Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, Ruol A.

J Med Virol. 1991 Jun;34(2):132-5.PMID: 1890413 [PubMed - indexed for MEDLINE]Related articles

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.

Imagawa A, Itoh N, Hanafusa T, Oda Y, Waguri M, Miyagawa J, Kono N, Kuwajima M, Matsuzawa Y.

J Clin Endocrinol Metab. 1995 Mar;80(3):922-6.PMID: 7883851 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

Betterle C, Fabris P, Zanchetta R, Pedini B, Tositti G, Bosi E, de Lalla F.

Diabetes Care. 2000 Aug;23(8):1177-81.PMID: 10937518 [PubMed - indexed for MEDLINE]Related articlesFree article

Thyroid autoimmunity and dysfunction associated with type I interferon therapy.

Monzani F, Caraccio N, Dardano A, Ferrannini E.

Clin Exp Med. 2004 Apr;3(4):199-210. Review.PMID: 15103510 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity and antibodies to interferons in patients with carcinoid tumors--clinical consequences.

Oberg KE.

J Interferon Res. 1994 Aug;14(4):215-6. No abstract available. PMID: 7822879 [PubMed - indexed for MEDLINE]Related articles

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.

Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde KH.

Hepatology. 1989 Jul;10(1):24-8.PMID: 2737600 [PubMed - indexed for MEDLINE]Related articles

[Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C]

Heller J, Musiolik J, Homrighausen A, Sauerbruch T, Spengler U.

Dtsch Med Wochenschr. 1996 Sep 27;121(39):1179-83. German. PMID: 8925742 [PubMed - indexed for MEDLINE]Related articles

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.

Burman P, Tötterman TH, Oberg K, Karlsson FA.

J Clin Endocrinol Metab. 1986 Nov;63(5):1086-90.PMID: 2944910 [PubMed - indexed for MEDLINE]Related articles

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a.

Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P.

Eur J Endocrinol. 1995 May;132(5):587-93.PMID: 7749499 [PubMed - indexed for MEDLINE]Related articles

Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.

Custro N, Montalto G, Scafidi V, Soresi M, Gallo S, Tripi S, Notarbartolo A.

J Endocrinol Invest. 1997 Jul-Aug;20(7):374-80.PMID: 9309534 [PubMed - indexed for MEDLINE]Related articles